Monday, June 25, 2007

CATT Study Update

Thanks to a reliable (but unofficial) source, I have learned that the people running the CATT study (Comparison of Age-Related Macular Degeneration Treatments Trials) have scheduled a meeting for September, and hope to get the study underway shortly thereafter (by late Fall).

The Comparison of Age-Related Macular Degeneration Treatments Trials (CATT) is a set of multicenter, randomized clinical trials of treatments for neovascular age-related macular degeneration (AMD), the leading cause of blindness in the United States. The Lucentis-Avastin Trial, supported by the National Eye Institute will be the first CATT clinical trial.

Irv Arons


At 1:07 PM, Anonymous Anonymous said...

Are there any trials comparing Lucentis with Avantis for the treatment of proliferative diabetic retinopathy or are any being planned?

At 10:11 AM, Blogger Irv Arons said...

Dan Roberts of the MD Forum found one study -- "Bevacizumab Versus Ranibizumab for Diabetic Retinopathy", sponsored by The Medical University of Vienna, and started in October 2007. Here is the link:

I hope this is of some help.

Irv Arons


Post a Comment

<< Home